Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
name
Illumina
ILMN.US
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.
617.29 B
ILMN.USMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
Life Sciences Tools and ServicesIndustry
Industry Ranking4/59
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE33.82%A
    • Profit Margin19.42%A
    • Gross Margin67.64%A
  • Growth ScoreC
    • Revenue YoY1.29%C
    • Net Profit YoY188.30%A
    • Total Assets YoY6.10%C
    • Net Assets YoY13.01%B
  • Cash ScoreC
    • Cash Flow Margin132.24%B
    • OCF YoY1.29%C
  • Operating ScoreB
    • Turnover0.69B
  • Debt ScoreD
    • Gearing Ratio59.20%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --